 Vaxart Inc. NASDAQ: VXRT shares pushed higher Monday after the company made an announcement stating the U.S. Food and Drug Administration cleared its Investigational New Drug application for an S-only oral tablet SARS-CoV-2 vaccine candidate. Vaxart was up 11.13 at 7.99 at last check Monday. 